Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
최신 재무제표(Form-10K)에 따르면, Cryo-Cell International Inc의 총 자산은 $64이며, 순손실입니다.
CCEL의 주요 재무 비율은 무엇인가요?
Cryo-Cell International Inc의 유동비율은 0.83이고, 순이익률은 0, 주당 매출은 $3.77입니다.
Cryo-Cell International Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Cryo-Cell International Inc 주요 수익원은 Umbilical Cord Blood and Cord Tissue Stem Cell Service이며, 최신 수익 발표에서 수익은 31,551,550입니다. 지역별로는 United States이 Cryo-Cell International Inc의 주요 시장이며, 수익은 31,986,106입니다.
Cryo-Cell International Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Cryo-Cell International Inc의 순손실은 $0입니다.